Spiegel C A, Huycke M
Department of Medical Microbiology, University of Wisconsin, Madison.
Arch Intern Med. 1989 Aug;149(8):1873-5.
A case of community-acquired endocarditis caused by Enterococcus (Streptococcus) faecalis with high-level resistance to gentamicin sulfate but not to streptomycin sulfate is described. Killing curves performed using achievable serum levels showed synergistic killing when streptomycin but not gentamicin, tobramycin, or amikacin was combined with penicillin G sodium or vancomycin hydrochloride. Combination therapy with vancomycin and streptomycin resulted in cure. Serum bactericidal levels indicated activity of the synergistic, as well as a nonsynergistic (vancomycin plus gentamicin), combination. Routine screening of blood isolates for high-level resistance to streptomycin and gentamicin can provide guidance for selection of therapeutic combinations in serious enterococcal infections, including endocarditis.
本文描述了1例由粪肠球菌(链球菌)引起的社区获得性心内膜炎病例,该菌对硫酸庆大霉素具有高水平耐药性,但对硫酸链霉素不耐药。使用可达到的血清水平进行的杀菌曲线显示,当链霉素而非庆大霉素、妥布霉素或阿米卡星与青霉素G钠或盐酸万古霉素联合使用时,呈现协同杀菌作用。万古霉素和链霉素联合治疗使患者痊愈。血清杀菌水平表明了协同组合以及非协同组合(万古霉素加庆大霉素)的活性。对血液分离株进行链霉素和庆大霉素高水平耐药性的常规筛查可为包括心内膜炎在内的严重肠球菌感染治疗组合的选择提供指导。